Health
BioNTech Stock Pops Ahead Of Earnings; But Can Its Vaccine Tackle Delta? – Investor’s Business Daily
BioNTech stock popped Monday after the Covid-vaccine maker said it would announce second-quarter earnings results in a week.
BioNTech stock popped Monday after the Covid vaccine maker said it would announce second-quarter earnings results in a week.
XAnalysts polled by FactSet expect BioNTech (BNTX) to report adjusted earnings of $8.94 per share and almost $3.86 billion in sales….
Continue Reading